Delivery Order SPE2DB22D1017-SPE2DB24FG3ZE

Award Date 8/26/24
Potential Completion Date 8/27/24
Potential Value $13K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $48,980.22, is for the supply of Stelara 90 mg/ml syringes, a specialty medication. The contract has a completion date of July 9, 2024 and is a firm fixed price delivery order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of STELARA 90 MG/ML syringes, a specialty pharmaceutical product, with a ceiling value of $13,725.85 and a completion date of September 18, 2024. The contract is a Firm Fixed Price type with no set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to provide a wide...
This is a $7,455.14 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of Stelara 90 mg/mL syringes. The contract has an ultimate completion date of April 30, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds a large Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025, for a wide range of...
This is a delivery order contract awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $27,566.42 firm fixed-price contract provides STELARA 90 MG/ML syringes to support federal government healthcare programs. The contract has an ultimate completion date of June 26, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $15,060.83, is for the supply of STELARA 90 MG/ML syringes. The contract is a firm fixed-price arrangement with a completion date of January 23, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $26,236.93, is for the procurement of Stelara 90 mg/ml syringes. The contract is a firm-fixed-price delivery order with an ultimate completion date of July 25, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,869.48, is for the delivery of STELARA 90 MG/ML SYRINGEML, a specialty medication. The contract has a firm fixed price and an ultimate completion date of August 9, 2024. AmerisourceBergen, a for-profit organization, is the prime contractor, and there are no set-aside requirements mentioned. This...
This is a $40,382.04 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of Stelara 90 mg/mL syringes. The contract has an ultimate completion date of August 6, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this delivery order as part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025. This IDC allows the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $114,787.52, is for the supply of STELARA 90 MG/ML SYRINGEML, a specialty pharmaceutical product. The contract has a completion date of July 11, 2024 and is a firm fixed-price delivery order. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of STELARA 90 MG/ML SYRINGEML, a specialty pharmaceutical product. The $20,113.55 firm fixed price contract has an ultimate completion date of August 7, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB24FG3ZE
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $13,242.64 firm fixed-price contract is for the supply of Stelara 90 mg/ml syringes, a specialty pharmaceutical product. The order has an ultimate completion date of August 27, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025 for a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to supply critical care medications and medical supplies to various government agencies and healthcare programs. The contract does not have a set-aside designation.

Generated 11/25/24, 9:03 AM